Optimer Pharmaceuticals
A biopharmaceutical company focused on discovering, developing and commercializing.
Launch date
Employees
Market cap
AUD451.5b
Enterprise valuation
AUD492.3b (Public information from Sep 2024)
Share price
$118.64 MRK
San Diego California (HQ)
Authorizing premium user...